Pembrolizumab, Bevacizumab, and Binimetinib

Who we are

  • April 5, 2022
    Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer

Discover the Art of Dance

Discover the Art of Dance

Whether you prefer ballet, jazz, or hip hop , we have a class for you.